After Hours Gainers:
Companies trading higher in after hours in reaction to news: AMGN +0.3% (presented additional findings from its exploratory Phase 2 trial of romosozumab: results showed increased estimated bone strength at the spine and hip; announced positive long-term results from Phase 3 FREEDOM study of Prolia (denosumab) in patients with osteoporosis)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings: FMC -9.4%, R -7.5%
Companies trading lower in after hours in reaction to news: COLL -9.2% (announced the FDA will not be able to complete its review of the New Drug Application for Xtampza by the PDUFA date of October 12, 2015), FIG -5.3% (Bloomberg reporting co is planning on closing macro Michael Novogratz hedge fund), JBLU -2.4% (reported September traffic: increase in RPMs of 13.3% Y/Y to ~3.09 bln, on a capacity increase of 13.1%), SKYW -0.6% (reported September 2015 block hours decreased 11.5% from prior year to 162,742)
After Hours Summary: FMC -9.4%, R -7.5% following earnings/guidance